Henry Schein Inc (HSIC) Stock Price, Quote & News

Company Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PP...

Industry: Medical Distribution

Sector: Healthcare

Phone: 631 843 5500

Website: www.henryschein.com

Address:

135 Duryea Road, Melville, United States

StockAutoPro Aug. 11 at 6:05 AM

$HSIC: Buy target $63.94 Sell target $69.24 Rising demand for telehealth services could boost stock prices for leading virtual healthcare providers.

0 · Reply

JarvisFlow Aug. 6 at 3:46 PM

UBS has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Neutral with a target price of 75 → 70.

0 · Reply

JarvisFlow Aug. 6 at 1:51 PM

Evercore ISI Group has updated their rating for Henry Schein ( $HSIC ) to In-Line with a price target of 70.

0 · Reply

JarvisFlow Aug. 6 at 1:00 PM

Barrington Research has updated their rating for Henry Schein ( $HSIC ) to Outperform with a price target of 78.

0 · Reply

ZacksResearch Aug. 5 at 5:29 PM

$HSIC missed on earnings but beat revenue in Q2’25. What’s the outlook? 🤔 💡 EPS of $1.10 missed estimates by 6.8% and fell 10.6% from the year-ago period, while revenues grew 3.2% to $3.24B, topping consensus by 0.6%. Despite margin contraction, the company is advancing its BOLD+1 Strategic Plan for 2025-2027. Discover more about HSIC's strategy and future prospects 👉 https://www.zacks.com/stock/news/2667344/henry-schein-stock-falls-on-q2-earnings-miss-revenues-top?cid=sm-stocktwits-2-2667344-body-5964&ADID=SYND_STOCKTWITS_TWEET_2_2667344_BODY_5964

0 · Reply

ZacksResearch Aug. 5 at 1:32 PM

$HSIC drops on Q2 miss — is this a buying opportunity or a red flag? EPS missed estimates by 6.8%, but revenue actually beat, rising 3.2% with strength across key segments. Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2667344/henry-schein-stock-falls-on-q2-earnings-miss-revenues-top?cid=sm-stocktwits-2-2667344-teaser-5941&ADID=SYND_STOCKTWITS_TWEET_2_2667344_TEASER_5941

0 · Reply

ZacksResearch Aug. 5 at 1:22 PM

$HSIC drops on earnings miss — but is the selloff overdone? Q2 EPS missed estimates by 6.8%, but revenues actually beat with 3.2% growth and solid performance across core segments. Full breakdown here 👉 https://www.zacks.com/stock/news/2667344/henry-schein-stock-falls-on-q2-earnings-miss-revenues-top?cid=sm-stocktwits-2-2667344-teaser-5932&ADID=SYND_STOCKTWITS_TWEET_2_2667344_TEASER_5932

0 · Reply

ZacksResearch Jul. 29 at 1:01 PM

$HSIC set for a potential earnings beat? 🔍 Henry Schein boasts an Earnings ESP of +2.37% and holds a Zacks Rank #3. With stable dental and medical market conditions, plus growth in global specialty products, HSIC might surprise investors this quarter. Full earnings preview here 👉 https://www.zacks.com/stock/news/2633048/henry-schein-to-report-q2-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2633048-body-4373&ADID=SYND_STOCKTWITS_TWEET_2_2633048_BODY_4373

0 · Reply

ZacksResearch Jul. 29 at 11:41 AM

Can $HSIC deliver a surprise this quarter? 👀 Q2 earnings are on deck, and investors will be watching closely for any signals on the stock’s near-term direction. Full preview here 👉 https://www.zacks.com/stock/news/2633048/henry-schein-to-report-q2-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2633048-teaser-4355&ADID=SYND_STOCKTWITS_TWEET_2_2633048_TEASER_4355

0 · Reply

JarvisFlow Jul. 25 at 12:00 PM

Stifel has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Hold with a target price of 80 → 75.

0 · Reply

Henry Schein, Inc. (HSIC) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 10:16 AM EDT - 6 days ago

Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution

Aug 5, 2025, 7:40 AM EDT - 7 days ago

Henry Schein falls after missing quarterly profit estimates

Aug 5, 2025, 6:00 AM EDT - 7 days ago

Henry Schein Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 1:24 PM EDT - 11 days ago

Henry Schein: Still Bullish Even As Shares Languish

Jul 30, 2025, 6:30 AM EDT - 13 days ago

Henry Schein One Launches Forms to Make Patient Check-In Easier and Faster

Jul 22, 2025, 6:30 AM EDT - 21 days ago

Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET

Jul 17, 2025, 9:16 AM EDT - 26 days ago

IntelePeer Joins Henry Schein One Academic Partner Program

Jul 15, 2025, 7:05 AM EDT - 4 weeks ago

Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025

Jun 2, 2025, 6:45 PM EDT - 2 months ago

Updated: Henry Schein to Participate in Upcoming Investor Conference in June

May 20, 2025, 6:30 AM EDT - 3 months ago

Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%

May 17, 2025, 9:30 AM EDT - 3 months ago

Henry Schein Post Earnings Review

May 16, 2025, 4:10 PM EDT - 3 months ago

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

May 15, 2025, 6:30 AM EDT - 3 months ago

Henry Schein to Participate in Upcoming Investor Conference in June

May 6, 2025, 9:36 AM EDT - 3 months ago

These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results

May 6, 2025, 6:30 AM EDT - 3 months ago

Henry Schein to Participate in Upcoming Investor Conferences in May

May 5, 2025, 4:26 PM EDT - 3 months ago

Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript

May 5, 2025, 8:49 AM EDT - 3 months ago

Henry Schein misses quarterly revenue estimates on weak demand for dental products

May 5, 2025, 6:00 AM EDT - 3 months ago

Henry Schein Reports First Quarter 2025 Financial Results

Apr 22, 2025, 6:30 AM EDT - 4 months ago

Henry Schein Medical Announces Winner of Its 2025 Rising Star Award

Apr 8, 2025, 6:30 AM EDT - 4 months ago

Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET

Apr 7, 2025, 6:30 AM EDT - 4 months ago

Henry Schein Received Validation of Net-Zero Science-Based Targets

Mar 31, 2025, 9:30 AM EDT - 4 months ago

IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor

Mar 25, 2025, 9:00 AM EDT - 5 months ago

Henry Schein Will Showcase a Selection of the Company's Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show

Mar 11, 2025, 6:30 AM EDT - 5 months ago

Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year

Mar 11, 2025, 4:25 AM EDT - 5 months ago

Henry Schein Looks Bullish (Technical Analysis)

Mar 4, 2025, 5:57 PM EST - 5 months ago

Henry Schein: An Industry Leader That Offers Some Upside From Here

Mar 3, 2025, 6:30 AM EST - 5 months ago

Henry Schein to Participate in Upcoming Investor Conference in March

Feb 26, 2025, 6:30 AM EST - 5 months ago

Nominations Now Open for Henry Schein Medical's Athletics and Schools 2025 Rising Star Award

Feb 25, 2025, 4:09 PM EST - 5 months ago

Henry Schein, Inc. (HSIC) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 11:51 AM EST - 5 months ago

Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth

Feb 25, 2025, 8:07 AM EST - 6 months ago

Henry Schein forecasts 2025 profit below estimates on weak demand for dental products

Feb 25, 2025, 6:00 AM EST - 6 months ago

Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance

Feb 12, 2025, 6:30 AM EST - 6 months ago

Henry Schein Chairman and CEO Stanley M. Bergman Receives National Association of Wholesaler-Distributors Dirk Van Dongen Lifetime Achievement Award

Feb 10, 2025, 6:30 AM EST - 6 months ago

Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

Jan 31, 2025, 10:30 PM EST - 6 months ago

Japan In The Spotlight; Blockchain In AI's Shadow

APO BBJP DBJP DFJ DXJ EWJ EWJV

Jan 29, 2025, 7:00 AM EST - 6 months ago

Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance

KKR

Jan 29, 2025, 5:45 AM EST - 6 months ago

KKR builds stake in Henry Schein, reaches deal for board seats, WSJ reports

KKR

Jan 23, 2025, 6:30 AM EST - 7 months ago

Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET

Jan 22, 2025, 4:37 PM EST - 7 months ago

Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say

Jan 16, 2025, 6:42 AM EST - 7 months ago

Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein

Jan 15, 2025, 6:30 AM EST - 7 months ago

Henry Schein Completes Acquisition of Acentus

Jan 14, 2025, 9:25 AM EST - 7 months ago

Henry Schein Opens Henry Schein Cares Foundation 2025 Relief Fund and Commits Up to $300,000 in Cash and Essential Health Care Supplies to Support the City of Los Angeles

Jan 9, 2025, 6:30 AM EST - 7 months ago

Henry Schein Opens Customer Emergency Support Hotline in Response to California Fires

Jan 7, 2025, 12:03 PM EST - 7 months ago

Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst

CAH

Dec 17, 2024, 6:30 AM EST - 8 months ago

Henry Schein to Participate at J.P. Morgan's Healthcare Investor Conference

Nov 23, 2024, 7:47 AM EST - 9 months ago

Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits

Nov 21, 2024, 6:30 AM EST - 9 months ago

Henry Schein to Participate in Investor Conferences in December

Nov 20, 2024, 6:30 AM EST - 9 months ago

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

Nov 18, 2024, 1:35 PM EST - 9 months ago

Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say

StockAutoPro Aug. 11 at 6:05 AM

$HSIC: Buy target $63.94 Sell target $69.24 Rising demand for telehealth services could boost stock prices for leading virtual healthcare providers.

0 · Reply

JarvisFlow Aug. 6 at 3:46 PM

UBS has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Neutral with a target price of 75 → 70.

0 · Reply

JarvisFlow Aug. 6 at 1:51 PM

Evercore ISI Group has updated their rating for Henry Schein ( $HSIC ) to In-Line with a price target of 70.

0 · Reply

JarvisFlow Aug. 6 at 1:00 PM

Barrington Research has updated their rating for Henry Schein ( $HSIC ) to Outperform with a price target of 78.

0 · Reply

ZacksResearch Aug. 5 at 5:29 PM

0 · Reply

ZacksResearch Aug. 5 at 1:32 PM

0 · Reply

ZacksResearch Aug. 5 at 1:22 PM

0 · Reply

ZacksResearch Jul. 29 at 1:01 PM

0 · Reply

ZacksResearch Jul. 29 at 11:41 AM

0 · Reply

JarvisFlow Jul. 25 at 12:00 PM

Stifel has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Hold with a target price of 80 → 75.

0 · Reply

LewisDaKat Jul. 14 at 10:25 PM

News HSIC Price Target Alert: $75.00. Issued by Leerink Partners https://marketwirenews.com/news-releases/hsic-price-target-alert-75-00-issued-by-leerink-part-4750681202439977.html $HSIC

0 · Reply

Estimize Jul. 14 at 1:01 PM

Wall St is expecting 1.20 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co

0 · Reply

JarvisFlow Jul. 14 at 11:30 AM

Baird updates rating for Henry Schein ( $HSIC ) to Neutral, target set at 82 → 72.

0 · Reply

JarvisFlow Jul. 9 at 1:00 PM

Evercore ISI Group has updated their rating for Henry Schein ( $HSIC ) to In-Line with a price target of 78.

0 · Reply

Estimize Jul. 8 at 1:00 PM

Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co

0 · Reply

ZacksResearch Jul. 7 at 1:17 PM

$HSIC rose 15.3% in the past year compared to the industry’s 1.1% growth. 📈 Henry Schein One is fueling growth with new solutions and partnerships, while acquisitions like Acentus and R. Weinstein, Inc. are expanding its product lines. However, macroeconomic pressures and fierce competition remain challenges. Opportunity assessment here 👉 https://www.zacks.com/commentary/2565482/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2565482-body-820&ADID=SYND_STOCKTWITS_TWEET_2_2565482_BODY_820

0 · Reply

Estimize Jul. 7 at 1:00 PM

Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co

0 · Reply

ZacksResearch Jul. 7 at 11:19 AM

$HSIC looks strong on digital growth — but is it enough? Henry Schein One is driving optimism, but macro headwinds and intense competition are tough to ignore. Opportunity vs. risk — full breakdown here 👉 https://www.zacks.com/stock/news/2565482/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2565482-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2565482_TEASER

0 · Reply

RunnerSignals Jun. 26 at 3:42 AM

Short Squeeze Watch $RMBS $VEEV $VRNA $MASI $HSIC are catching attention with rising trends and shifting short interest. Could a squeeze be brewing? https://stocksrunner.com/news/2025-06-25-13-high-short-interest-stocks-primed-for-a-short-squeeze

1 · Reply

Estimize Jun. 23 at 1:03 PM

Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co

0 · Reply

swingingtech Jun. 4 at 9:53 PM

$CIEN $HSIC $RNA https://wallstreetwaves.com/key-wednesday-options-activity-cien-hsic-rna/

0 · Reply

OptionRunners Jun. 4 at 6:27 PM

$HSIC Seller of the July 18th $75/$80 call spreads 5,000 times for $0.86. Looks to be closing those out for a loss.

0 · Reply

Market Cap	8.00B
Revenue (ttm)	12.67B
Net Income (ttm)	390.00M
EPS (ttm)	N/A
PE Ratio	14.14
Forward PE	13.61
Profit Margin	3.08%
Debt to Equity Ratio	0.51

Volume	2,099,300
Avg Vol	1,830,366
Day's Range	N/A - N/A
Shares Out	121.27M
Stochastic %K	39%
Beta	0.81
Analysts	Sell
Price Target	$72.92